Article Versions Notes

Chen I-C, Wang S-C, Chen Y-T, Tseng H-H, Liu P-L, Lin T-C, Wu H-E, Chen Y-R, Tseng Y-H, Hsu J-H, et al. Corylin Ameliorates LPS-Induced Acute Lung Injury via Suppressing the MAPKs and IL-6/STAT3 Signaling Pathways. Pharmaceuticals. 2021; 14(10):1046. https://doi.org/10.3390/ph14101046

Chen, I-Chen, Shu-Chi Wang, Yi-Ting Chen, Hsin-Han Tseng, Po-Len Liu, Tzu-Chieh Lin, Hsin-En Wu, Yuan-Ru Chen, Yu-Hsin Tseng, Jong-Hau Hsu, and et al. 2021. "Corylin Ameliorates LPS-Induced Acute Lung Injury via Suppressing the MAPKs and IL-6/STAT3 Signaling Pathways" Pharmaceuticals 14, no. 10: 1046. https://doi.org/10.3390/ph14101046

Chen, I. -C., Wang, S. -C., Chen, Y. -T., Tseng, H. -H., Liu, P. -L., Lin, T. -C., Wu, H. -E., Chen, Y. -R., Tseng, Y. -H., Hsu, J. -H., Dai, Z. -K., Suen, J. -L., & Li, C. -Y. (2021). Corylin Ameliorates LPS-Induced Acute Lung Injury via Suppressing the MAPKs and IL-6/STAT3 Signaling Pathways. Pharmaceuticals, 14(10), 1046. https://doi.org/10.3390/ph14101046